MiniMed (MMED) Common Equity (2025 - 2026)

MiniMed (MMED) posted Common Equity of $3.6 billion for Q2 2026, up 4.3% on a QoQ basis from $3.5 billion in Q1 2026, and up 8.44% year-over-year from $3.3 billion in Q2 2025.

MiniMed (MMED) Common Equity (2025 - 2026) Analysis & Trends

MiniMed's Common Equity history runs 2 years deep, the most recent figure standing at $3.6 billion for Q2 2026.

  • Quarterly Common Equity rose 8.44% year-over-year to $3.6 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3.6 billion (up 8.44% YoY) and the FY2026 annual result came in at $3.6 billion, up 8.44% from the prior year.
  • Common Equity was $3.6 billion for Q2 2026 at MiniMed, up from $3.5 billion in the prior quarter.
  • Across five years, Common Equity topped out at $3.6 billion in Q2 2026 and bottomed at $3.3 billion in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Veeva Systems 32.28 Bn 24.97 Bn 662.02 Mn 7.30 Bn
2 BrightSpring Health Services 14.62 Bn 13.72 Bn 482.22 Mn 1.98 Bn
3 Healthequity 8.35 Bn 8.08 Bn 256.31 Mn 2.05 Bn
4 Hinge Health 5.98 Bn 5.67 Bn 154.23 Mn 111.69 Mn
5 10x Genomics 5.88 Bn 5.34 Bn 106.18 Mn 814.32 Mn
6 MiniMed 4.50 Bn 4.20 Bn 480.00 Mn 3.61 Bn
7 Waystar Holding 4.47 Bn 4.41 Bn 216.84 Mn 3.94 Bn
8 Doximity 3.96 Bn 3.21 Bn 125.97 Mn 950.84 Mn
9 Privia Health 3.13 Bn 2.71 Bn - 805.90 Mn
10 Omnicell 1.89 Bn 1.65 Bn 140.36 Mn 1.26 Bn

Historic Data

Download Data
DateValue
Apr 24, 2026 3.61 Bn
Jan 23, 2026 3.46 Bn
Apr 25, 2025 3.33 Bn
Jan 24, 2025 3.49 Bn